Investor List:

Top BioTech Series B Investors in Seattle / Portland (21)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top BioTech investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Ling Wong, Managing Partner at Highbury Group
Ling Wong
Highbury Group·Managing Partner
Sweet spot: $10.0M
Range: $500K - $50.0M
Investors in San Francisco (CA), Investors in Seattle (WA)
Investors in Consumer Health (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series B), Investors in Seattle / Portland (Other Lists), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Series B), Investors in Investors who were founders (Other Lists), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Series A), Investors in AI (Series A), Investors in AI (Series B), Investors in AI (Series B), Investors in AI (Series A)
Photo of YB (Yongbai) Choi, Investor at Vulcan Capital
YB (Yongbai) Choi
Vulcan Capital·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States, Investors in California, Investors in Bellevue (WA)
Investors in Games (Seed), Investors in AI (Series B), Investors in Robotics (Seed), Investors in BioTech (Series B), Investors in Games (Series B), Investors in Games (Series A), Investors in BioTech (Seed), Investors in Robotics (Series B), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Seattle / Portland (Other Lists), Investors in Health IT (Series A), Investors in AI (Seed), Investors in AI (Seed), Investors in Health & Hospital Services (Series B), Investors in AI (Series A), Investors in BioTech (Seed), Investors in Games (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Robotics (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Games (Series A), Investors in Health IT (Series A), Investors in Robotics (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in AI (Series B), Investors in Games (Series B), Investors in Health IT (Series B), Investors in Robotics (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of David Cremin, Managing Partner at Frontier Ventures
David Cremin
Frontier Ventures·Managing Partner
Sweet spot: $550K
Range: $100K - $1M
Investors in California, Investors in Los Angeles / Southern California, Investors in Santa Barbara (CA), Investors in Sacramento (CA), Investors in Portland (OR), Investors in Oregon, Investors in Washington
Investors in AI (Series B), Investors in BioTech (Series B), Investors in Media/Content (Seed), Investors in IoT (Seed), Investors in IoT (Series B), Investors in Media/Content (Series B), Investors in BioTech (Seed), Investors in IoT (Series A), Investors in Media/Content (Series A), Investors in Seattle / Portland (Other Lists), Investors in BioTech (Series A), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in AI (Series A), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in BioTech (Seed), Investors in IoT (Seed), Investors in IoT (Seed), Investors in Media/Content (Seed), Investors in Media/Content (Seed), Investors in Media/Content (Seed), Investors in IoT (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in IoT (Series A), Investors in Media/Content (Series A), Investors in IoT (Series A), Investors in Media/Content (Series A), Investors in IoT (Series A), Investors in BioTech (Series B), Investors in Media/Content (Series A), Investors in AI (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Media/Content (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in IoT (Series B), Investors in IoT (Series B), Investors in IoT (Series B), Investors in Media/Content (Series B), Investors in Media/Content (Series B), Investors in AI (Seed)
Photo of Steven Gillis, Managing Director at ARCH Venture Partners
Steven Gillis
ARCH Venture Partners·Managing Director
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Seattle (WA)
Photo of Leen Kawas, General Partner at Propel Bio Partners
Leen Kawas
Propel Bio Partners·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Seattle (WA)
Photo of William Canestaro, Managing Director at WRF Capital
William Canestaro
WRF Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Seattle (WA)
Photo of Loretta Little, Managing Director at WRF Capital
Loretta Little
WRF Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Seattle (WA)
Investors in Medical Devices (Seed), Investors in SMB Software (Seed), Investors in BioTech (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Seattle / Portland (Other Lists), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in Consumer Internet (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Consumer Internet (Seed), Investors in SMB Software (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Consumer Internet (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in SMB Software (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in SMB Software (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Consumer Internet (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Rob Carlson, Managing Director at Bioeconomy Capital
Rob Carlson
Bioeconomy Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Seattle (WA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Seattle / Portland (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series B)